Home / DBD : NYSE

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does DBD make money? Does DBD have pricing power? What's the Earnings Whisper? Will DBD profit more as the business scales? What is DBD's management track record? Is DBD's current price justified?

Diebold Nixdorf, Incorporated

$55.05 -$8.91 (-13.93%)

NYSE · 30 Oct 2026 20:00 UTC

Previous Close

$59.14

Day Range

$52.87$58.39

Year Range

$52.87$92.09

Market Cap

1.85B

AVG Volume

285.03K

Trailing/Forward PE

25.25/8.97

PEG ratio

1.1

Dividend Yield

Next Earnings Date

2027-02-11

Primary Exchange

New York Stock Exchange

Revenue (USD) · A

DBD Revenue (USD) by year
Period	Revenue (USD)
2025	3.81B
2024	3.75B
2023	3.76B
2022	3.46B
2021	3.91B
2020	3.9B
2019	4.41B
2018	4.58B
2017	4.61B
2016	3.32B

Net Income (USD) · A

DBD Net Income (USD) by year
Period	Net Income (USD)
2025	94.6M
2024	-16.5M
2023	1.38B
2022	-581.4M
2021	-78.8M
2020	-269.1M
2019	-341.3M
2018	-590.6M
2017	-233.7M
2016	-33M

Operating Income (USD) · A

DBD Operating Income (USD) by year
Period	Operating Income (USD)
2025	321.9M
2024	182.1M
2023	86.9M
2022	-211.7M
2021	137.1M
2020	24M
2019	-26.6M
2018	-385.7M
2017	-84.6M
2016	-159.8M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (USD) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Feb 2027.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Diebold Nixdorf, Incorporated

Earnings: DBD

Video analysis: DBD

News: DBD

Similar companies